X-SyndAct Master Protocol v1.0: European Syndromic Adaptive Clinical Trial for Pathogen X (X-SyndAct)
X-SyndAct is a Phase II-III randomised controlled, adaptive platform trial on therapeutics for new pathogens with pandemic potential in hospitalised patients, part of the EU-SyndAct programme of PROACT EU-Response. This is the master protocol, version 1.0. Interventions are described in the pathogen-specific master protocols. Sponsor: to be determined. Based on the EU-PEARL Master Protocol Template (EU-PEARL Consortium, 2023). Funded by the European Union under Grant Agreement No. 101156304.
Authors
- PROACT EU-Response Consortium
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-10-30
- DOI
- https://doi.org/10.5281/zenodo.23809286
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission